Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B | Gut

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BSG

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article metrics

Hepatology

Original research

Cost-effectiveness of antiviral treatment in adult patients with immune-tolerant phase chronic hepatitis B

Online download statistics by month:

Online download statistics by month: November 2020 to March 2024

	Abstract	Full	Pdf
Nov 2020	887	59	38
Dec 2020	1188	96	55
Jan 2021	442	35	27
Feb 2021	190	20	16
Mar 2021	293	20	14
Apr 2021	202	30	18
May 2021	77	23	19
Jun 2021	45	42	18
Jul 2021	20	19	9
Aug 2021	25	25	12
Sep 2021	32	31	21
Oct 2021	929	87	57
Nov 2021	481	65	43
Dec 2021	331	52	32
Jan 2022	249	37	22
Feb 2022	231	30	20
Mar 2022	259	48	24
Apr 2022	398	36	33
May 2022	261	27	21
Jun 2022	235	40	16
Jul 2022	243	41	25
Aug 2022	243	31	19
Sep 2022	173	21	18
Oct 2022	314	30	15
Nov 2022	222	13	3
Dec 2022	143	10	3
Jan 2023	171	13	9
Feb 2023	202	14	7
Mar 2023	281	32	16
Apr 2023	115	17	14
May 2023	134	15	6
Jun 2023	90	5	4
Jul 2023	140	7	9
Aug 2023	129	13	6
Sep 2023	111	8	4
Oct 2023	152	11	3
Nov 2023	110	9	10
Dec 2023	233	10	7
Jan 2024	161	7	8
Feb 2024	163	7	6
Mar 2024	126	12	12
Total	10431	1148	719